Peripheral T cell lymphoma is a rare group of non Hodgkin lymphomas that originates from mature T cells. These cells normally help the immune system identify and respond to . . .
Ocrevus, also known as ocrelizumab, is an infusion treatment used for certain forms of multiple sclerosis. Before an infusion, healthcare professionals generally review a person's medical history, current medications, . . .
Ocrevus, also known as ocrelizumab, is a treatment used for certain forms of multiple sclerosis. Because it affects B cells involved in the immune system, ongoing follow up is . . .
Primary progressive multiple sclerosis or PPMS is characterized by a gradual worsening of neurological function from the beginning of the disease, rather than distinct relapses and recoveries. Ocrevus, also . . .
Multiple sclerosis is a condition in which the immune system can damage the protective covering of nerves in the central nervous system. Relapsing forms of MS can involve periods . . .
Ocrevus, also known by its generic name ocrelizumab, is a monoclonal antibody used for certain forms of multiple sclerosis. It is administered through intravenous infusion, meaning the medicine enters . . .
Ocrevus, also known as ocrelizumab, is an intravenous medicine used for certain forms of multiple sclerosis. Because it affects B cells involved in immune function, appropriate screening and monitoring . . .
Multiple sclerosis is a neurological condition in which the immune system mistakenly attacks myelin, the protective covering around nerve fibers in the central nervous system. This immune activity can . . .
Ocrevus, also known by its generic name ocrelizumab, is a disease modifying treatment used for specific forms of multiple sclerosis. It is a CD20 directed monoclonal antibody that works . . .
Ocrevus, also known as ocrelizumab, is a prescription medicine used to treat certain forms of multiple sclerosis, including relapsing forms and primary progressive multiple sclerosis in appropriate patients. It . . .